Fentanyl Phase 2 Trial met all endpoints; Phase 3 planned for H1 2027 CAMBRIDGE, Mass., Oct. 1, 2026 /PRNewswire/ -- Clear Scientific, Inc. today announced positive top-line results from its Phase 2 trial of CS-1103, a small-molecule sequestrant that immediately binds and inactivates...
Hence then, the article about clear scientific reports positive phase 2 results for cs 1103 the first investigational therapeutic that removes fentanyl from the body was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Clear Scientific Reports Positive Phase 2 Results for CS-1103, the First Investigational Therapeutic That Removes Fentanyl from the Body )
Also on site :
- In 1991, Gary Erickson spent six months kitchen-testing Clif Bar recipes after a bad bike ride; 31 years later, he sold the company to Mondelez for $2.9 billion
- Apple’s New Holiday Ad Is Bringing the Internet to Tears — and It’s Sending a Powerful Message About AI
- Vermont Families Reunited With National Guard Soldiers After Nearly a Year Apart
